Breast conservation therapy for invasive carcinoma of the breast (Q40607964)

22 September 2017

1 reference

title

Breast conservation therapy for invasive carcinoma of the breast (English)

1 reference

22 September 2017

1 reference

Borgen PI

1

1 reference

22 September 2017

Heerdt AS

series ordinal

2

1 reference

22 September 2017

Moore MP

series ordinal

3

1 reference

22 September 2017

Petrek JA

series ordinal

4

1 reference

22 September 2017

publication date

1 March 1995

1 reference

Current Problems in Surgery

22 September 2017

published in

1 reference

22 September 2017

volume

32

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

191-248

1 reference

The prognosis of carcinoma of the breast in relation to the type of operation performed

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

A review of 146 cases of carcinoma of the breast operated on between 1930 and 1943

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

A Comparison of Modified Radical Mastectomy to Radical Mastectomy in the Treatment of Operable Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Sounding board. Breast-cancer management: alternatives to radical mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast cancer 2000 BC to 2000 AD--time for a paradigm shift?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Long-term followup of breast cancer patients: the 30-year report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The Guy's trial of treatments of "early" breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

EARLY CARCINOMA OF THE BREAST

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Treatment of breast cancer by tumour extirpation and roentgen therapy instead of radical operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative treatment of breast carcinoma—review of 25 years follow up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Postoperative radiotherapy in the treatment of breast cancer: results of the NSABP clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

“Residual” mammary carcinoma following simulated partial mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The case against tylectomy for carcinoma of the breast. The factor of multicentricity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The extent and distribution of cancer in breasts with palpable primary tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Results of re-excisional biopsy of the primary tumor in preparation for definitive irradiation of patients with early stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Cancerous residue in breast-conserving surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Limited resection for breast cancer: a study of inked specimen margins before radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Radiation therapy as initial treatment for early stage cancer of the breast wiithout mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative management of operable breast cancer.Ten years experience at the Foundation Curie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservation surgery and irradiation for the treatment of favorable breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Treatment of early stage breast cancer by limited surgery and radical irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Local excision and radiation therapy for early stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast cancer: a 21 year experience with conservative surgery and radiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Radiation therapy with or without primary limited surgery for operable breast cancer: a 20-year experience at the Marseilles Cancer Institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservation surgery and irradiation as treatment for early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Wide excision of the tumor, axillary dissection, and postoperative radiotherapy as treatment of small breast cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative treatment of breast cancer: a report on 108 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservation surgery and irradiation as an alternative to mastectomy in the treatment of clinically favorable breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast conservation in the treatment of early breast cancer. A 20-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservation surgery and radiation therapy in the treatment of operable breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Excisional biopsy, axillary node dissection and definitive radiotherapy for Stages I and II breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Current status of conservative surgery and radiotherapy as primary local treatment for early carcinoma of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Review of conservative surgery in early breast cancer. British Columbia experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative management of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Radiation therapy as primary treatment for early stage carcinoma of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Local control and survival of breast cancer treated by limited surgery followed by irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast-conserving surgery with radiation therapy for operable mammary carcinoma: a 25-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservation treatment of early breast cancer: long term results and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast cancer. Experiences with conservation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Is it necessary to irradiate the breast after conservative surgery for localized cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus plus postoperative radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative treatment of early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative surgery with radiation therapy in clinical stage I and II breast cancer. Results of a 20-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Stage I and II breast carcinoma: treatment with limited surgery and radiation therapy versus mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Results of breast conserving treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative surgery and radiotherapy for early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative treatment for breast cancer: long-term results (15 years)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Ten year results of conservative surgery and irradiation for stage I and II breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Early-stage breast cancer: local control after conservative surgery and radiation therapy with immediate interstitial boost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative treatment of breast cancer with QU.A.R.T. Technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Local control and survival in early breast cancer: the Milan trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less the experience of the institut gustave-roussy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Limited surgical management for primary breast cancer: a commentary on the NSABP reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Lumpectomy and axillary dissection for breast cancer: surgical, pathological, and radiation considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Reanalyses of NSABP studies. National Surgical Adjuvant Breast and Bowel Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Patient selection criteria for conservation surgery versus mastectomy: Memorial Hospital breast service experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Consequences of breast irradiation in patients with pre-existing collagen vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast cancer during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Results of salvage surgery for mammary recurrence following breast-conserving therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The prognostic significance of late local recurrence after breast-conserving therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Significance of ipsilateral breast tumour recurrence after lumpectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Infiltrating lobular carcinoma of the breast treated with segmental and modified radical mastectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Time course and prognosis of mammary failure following breast-conserving therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

To boost or not to boost: decreasing radiation therapy in conservative breast cancer treatment when "inked" tumor resection margins are pathologically free of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The impact of tumor size and histology on local control after breast-conserving therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Risk factors in breast-conservation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: a review article for surgeons, pathologists, and radiation and medical oncologists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Effect of delay in radiation in the combined modality treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

What have we learned about risk factors for local recurrence after breast-conserving surgery and irradiation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Pathological features predictive of local recurrence after management by conservation of invasive breast cancer: importance of non-invasive carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast conservation management of breast tumors 4 cm or larger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Why are local recurrences after breast-conserving therapy more frequent in younger patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Multiple primary tumours in patients treated with radiotherapy for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservation therapy for breast cancers other than infiltrating ductal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Conservation therapy for invasive lobular carcinoma of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Radiotherapy after breast-preserving surgery in women with localized cancer of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Implications of accurate pathologic margins in the treatment of primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast cancer. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Mammary recurrences in women younger than forty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The second ten years: long-term risks of breast conservation in early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Patients with early breast cancer benefit from effective axillary treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Axillary node dissection for early breast cancer: some is good, but all is better

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Skip lesions in the axilla in breast cancer, and their association with micrometastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Distribution of axillary node metastases by level of invasion. An analysis of 539 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Results of conservative operations for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Put the “hockey stick” on ice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Three-field technique for breast irradiation using tangential field corner blocks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Primary management of carcinoma of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Arm edema in conservatively managed breast cancer: obesity is a major predictive factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Adjuvant antiestrogen therapy for breast cancer. Past, present, and future.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

c-erbB-2 protein expression in node negative breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Second malignancies after CMF for resectable breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Noninvasive cardiac evaluation of patients receiving adriamycin-containing adjuvant chemotherapy (FAC) for stage II or III breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Influence of radiotherapy on the dose of adjuvant chemotherapy in early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Partial mastectomy for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Segmental mastectomy without radiotherapy. Short-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer--a twenty three year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Results of wide excision for mammary recurrence after breast-conserving therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

Breast conservation: long-term Australian data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

inferred from DOI database lookup

7 January 2021

based on heuristic

A Danish randomized trial comparing breast-preserving therapy with mastectomy in mammary carcinoma. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0011-3840%2805%2980016-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0011-3840(05)80016-4

1 reference

22 September 2017

1 reference